CYP19A1 and breast carcinoma: Consistently, in the stromal adipocytes of breast cancer, PGE2 has upregulated aromatase production to stimulate tumor cell proliferation and promoted cell survival by inducing Bcl-2, the anti-apoptotic protein, via Ras-MAPK signaling [112, 113].